Cargando…
Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer
BACKGROUND: Human epidermal growth factor receptor HER3 (ErbB3), especially in association with its relative HER2 (ErbB2), is known as a key oncogene in breast tumour biology. Nonetheless, the prognostic relevance of HER3 remains controversial. NEDD4–1 and NRDP1 are signalling molecules closely rela...
Autores principales: | Luhtala, Satu, Staff, Synnöve, Kallioniemi, Anne, Tanner, Minna, Isola, Jorma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204010/ https://www.ncbi.nlm.nih.gov/pubmed/30367623 http://dx.doi.org/10.1186/s12885-018-4917-1 |
Ejemplares similares
-
Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1‐mediated ErbB3 ubiquitination and degradation
por: Wu, Yuxuan, et al.
Publicado: (2015) -
RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding
por: Wauman, Joris, et al.
Publicado: (2011) -
Expression of Estrogen-Related Receptors in Localized Provoked Vulvodynia
por: Aalto, Anu, et al.
Publicado: (2020) -
HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005
por: Köninki, Katri, et al.
Publicado: (2009) -
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
por: Alanko, Johanna, et al.
Publicado: (2021)